Synthesis of Doxorubicin and miRNA Stimuli-Sensitive Conjugates for Combination Therapy

Methods in Molecular Biology - RNA Interference and Cancer Therapy ◽

10.1007/978-1-4939-9220-1_8 ◽

2019 ◽

pp. 99-109

Author(s):

Daniel F. Costa ◽

Can Sarisozen ◽

Vladimir P. Torchilin

Keyword(s):

Combination Therapy ◽

Stimuli Sensitive

Download Full-text

Stimuli‐sensitive Linear‐dendritic Block Copolymer‐drug Prodrug As Nano‐platform for Tumor Combination Therapy

Advanced Materials ◽

10.1002/adma.202108049 ◽

2021 ◽

pp. 2108049

Author(s):

Hao Cai ◽

Ping Tan ◽

Xiaoting Chen ◽

Michal Kopytynski ◽

Dayi Pan ◽

...

Keyword(s):

Block Copolymer ◽

Combination Therapy ◽

Stimuli Sensitive

Download Full-text

Biocompatible polymeric nanocomplexes as an intracellular stimuli-sensitive prodrug for type-2 diabetes combination therapy

Biomaterials ◽

10.1016/j.biomaterials.2015.09.013 ◽

2015 ◽

Vol 73 ◽

pp. 149-159 ◽

Author(s):

Feng-Zhen Wang ◽

Zhi-Shen Xie ◽

Lei Xing ◽

Bing-Feng Zhang ◽

Jia-Liang Zhang ◽

...

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Stimuli Sensitive

Download Full-text

Polymeric nanocomplexes as an intracellular stimuli-sensitive prodrug for type-2 diabetes combination therapy

Frontiers in Bioengineering and Biotechnology ◽

10.3389/conf.fbioe.2016.01.02300 ◽

2016 ◽

Vol 4 ◽

Author(s):

Jiang Hulin ◽

Wang Feng-Zhen ◽

Xing Lei ◽

Xu Xiaojun

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Stimuli Sensitive

Download Full-text

High dose induction therapy with consensus interferon followed by combination therapy with ribavirin for treatment-naive hepatitis C patients

Gastroenterology ◽

10.1016/s0016-5085(01)81904-1 ◽

2001 ◽

Vol 120 (5) ◽

pp. A383-A383

Author(s):

S KALSER ◽

C KREYSEL ◽

H HASS ◽

M GREGOR

Keyword(s):

Hepatitis C ◽

Combination Therapy ◽

Induction Therapy ◽

High Dose ◽

Consensus Interferon ◽

Treatment Naïve

Download Full-text

Octreotide monotherapy versus combination therapy with octreotide and alpha-interferon in patients with metastatic neuroendocrine gastroenteropancreatic (GEP) carcinoma

Gastroenterology ◽

10.1016/s0016-5085(01)83796-3 ◽

2001 ◽

Vol 120 (5) ◽

pp. A762-A762

Author(s):

M WIED ◽

A SPRENGER ◽

H MUELLER ◽

K KLOSE ◽

R ARNOLD

Keyword(s):

Combination Therapy ◽

Alpha Interferon

Download Full-text

617: Combination Therapy with Plasmin-Cleaved Beta-2-Glycoprotein 1 and Docetaxel Inhibits the Growth of Orthotopically Implanted Tramp Murine Prostate Cancer Cells

The Journal of Urology ◽

10.1016/s0022-5347(18)37879-0 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 164-164

Author(s):

Daniel D. Cohen ◽

Weixin Lu ◽

Alan J. Schroit

Keyword(s):

Prostate Cancer ◽

Combination Therapy ◽

Cancer Cells ◽

Prostate Cancer Cells ◽

Download Full-text

Dry Eye Responds Best to Combination Therapy

Skin & Allergy News ◽

10.1016/s0037-6337(08)70087-1 ◽

2008 ◽

Vol 39 (2) ◽

pp. 69

Author(s):

CAROLINE HELWICK

Keyword(s):

Combination Therapy ◽

Download Full-text

Combination Therapy Often Best for Acne Management

Internal Medicine News ◽

10.1016/s1097-8690(05)70458-3 ◽

2005 ◽

Vol 38 (1) ◽

pp. 22

Author(s):

Debra Wood

Keyword(s):

Combination Therapy

Download Full-text

Combination Therapy for HCV Assessed

Internal Medicine News ◽

10.1016/s1097-8690(06)73816-1 ◽

2006 ◽

Vol 39 (13) ◽

pp. 48-49

Author(s):

MARY ELLEN SCHNEIDER

Keyword(s):

Combination Therapy

Download Full-text

Abstract #805218: Combination Therapy with Once Weekly GLP 1 Receptor Agonist Dulaglutide and Basal Insulin Analogues in Asian Indians with Type 2 Diabetes

Endocrine Practice ◽

10.1016/s1530-891x(20)39612-9 ◽

2020 ◽

Vol 26 ◽

pp. 117-118

Author(s):

Brijendra Srivastava

Keyword(s):

Type 2 Diabetes ◽

Combination Therapy ◽

Basal Insulin ◽

Receptor Agonist ◽

Asian Indians ◽

Insulin Analogues

Download Full-text